As reported in Fig 8B and 8C, a curbed tumor growth and an improved survival rate were observed in mice immunized with the Trx-8mer-flank E7-OVX313 antigen compared to the Trx-8mer-OVX313 control. Here, TXN is linked to neoplasm.